Literature DB >> 21837508

Comparison of antifungal activities of gentian violet and povidone-iodine against clinical isolates of Candida species and other yeasts: a framework to establish topical disinfectant activities.

Shigemi Kondo1, Yoko Tabe, Toshihiko Yamada, Shigeki Misawa, Toyoko Oguri, Akimichi Ohsaka, Takashi Miida.   

Abstract

We evaluated antifungal activity as assessed by the contact time in topical use of gentian violet (GV) and povidone-iodine (PI) against Candida strains. A total of 102 yeast isolates were used in this study. A markedly lower minimal inhibitory concentration (MIC)(90) of GV than of PI was detected for all yeast isolates. No remarkable difference in the MICs was observed among the identical strains isolated from different clinical sites for both GV and PI. Although the minimal fungicidal activities (MFCs) of PI were identical for all tested time points, the fungicidal activity of GV decreased during the time course of incubation. These results indicate that, whereas GV is more effective than PI, the topical disinfectant efficacy of GV should be estimated using the MFC(5 min) and not the MIC or the MFC(24 h) for overall prevention of catheter-related bloodstream infections and oral infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21837508     DOI: 10.1007/s11046-011-9458-y

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  18 in total

1.  An evaluation of the suitability of the European suspension test to reflect in vitro activity of antiseptics against clinically significant organisms.

Authors:  D N Payne; J R Babb; C R Bradley
Journal:  Lett Appl Microbiol       Date:  1999-01       Impact factor: 2.858

2.  [In vitro activity of methylrosaniline chloride (gentian violet) as disinfectant against Candida spp. and Trichosporon spp. isolated from blood samples].

Authors:  Shigemi Kondo; Toshihiko Yamada; Naotake Satoh; Katsu Saionji; Toyoko Oguri; Jun Igari
Journal:  Kansenshogaku Zasshi       Date:  2006-11

3.  Activity of gentian violet and brilliant green against some microorganisms associated with skin infections.

Authors:  P Bakker; H Van Doorne; V Gooskens; N F Wieringa
Journal:  Int J Dermatol       Date:  1992-03       Impact factor: 2.736

4.  Oral candidiasis and oral yeast carriage among institutionalised South African paediatric HIV/AIDS patients.

Authors:  Elaine Blignaut
Journal:  Mycopathologia       Date:  2007-02-12       Impact factor: 2.574

Review 5.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  The effect of gentian violet on virulent properties of Candida albicans.

Authors:  Su Ying; Sun Qing; Li Chunyang
Journal:  Mycopathologia       Date:  2009-11-24       Impact factor: 2.574

7.  In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies.

Authors:  Emilia Cantón; Javier Pemán; Amparo Valentín; Ana Espinel-Ingroff; Miguel Gobernado
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

8.  Patterns of amphotericin B killing kinetics against seven Candida species.

Authors:  Emilia Cantón; Javier Pemán; Miguel Gobernado; Angel Viudes; Ana Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

9.  The effect of chlorhexidine and gentian violet on the adherence of Candida spp. to urinary catheters.

Authors:  D P Camacho; A Gasparetto; T I E Svidzinski
Journal:  Mycopathologia       Date:  2007-04-11       Impact factor: 3.785

10.  Inactivation of influenza A virus by gentian violet (GV) and GV-dyed cotton cloth, and bactericidal activities of these agents.

Authors:  Ariaki Nagayama
Journal:  J Infect Chemother       Date:  2006-04       Impact factor: 2.211

View more
  2 in total

Review 1.  Gentian violet: a 19th century drug re-emerges in the 21st century.

Authors:  Alexander M Maley; Jack L Arbiser
Journal:  Exp Dermatol       Date:  2013-12       Impact factor: 3.960

2.  A Light-Activated Antimicrobial Surface Is Active Against Bacterial, Viral and Fungal Organisms.

Authors:  Tim Walker; Melisa Canales; Sacha Noimark; Kristopher Page; Ivan Parkin; Jane Faull; Manni Bhatti; Lena Ciric
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.